| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/09/2005 | US20050123898 Viral propagation mixture comprising expression vector, packaging cell line and donor plasmid for use in insertion, amplification, propagation and expression of heterologous gene sequences |
| 06/09/2005 | US20050123600 Compositions and methods for drug delivery using pH sensitive molecules |
| 06/09/2005 | US20050123596 pH-triggered microparticles |
| 06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
| 06/09/2005 | US20050123547 Methods for diagnosis and treatment of epithelial-derived cancers |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123536 Treatment of immunological disorders using anti-dc30 antibodies |
| 06/09/2005 | US20050123526 Administration of growth factors for neurogenesis and gliagenesis |
| 06/09/2005 | US20050123525 Composition and method for inducing immune tolerance towards cell, tissue and/or organ transplants |
| 06/09/2005 | US20050123524 Pharmaceutical compositions and methods for treating neuronal damages and neurodegenerative diseases |
| 06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
| 06/09/2005 | US20050123521 Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase |
| 06/09/2005 | US20050123517 Transducing a neuron with a transgene from the pseudotyped retrovirus virion; gene therapy for neurodegenerative diseases; Huntington's, Parkinson's and Alzheimer's Diseases, Amyotrophic Lateral Sclerosis, ataxia, atrophy, prion disease |
| 06/09/2005 | US20050123516 Delivering a neurotrophic formulation comprising a neurotrophin encoding lentiviral expression vector, into one or more delivery sites within a region of the brain containing targeted neurons expressed for therapy of brain disorder |
| 06/09/2005 | US20050123515 retroviral vectors comprising nucleotide sequences that code envelope proteins, capable of transduction to target site |
| 06/09/2005 | US20050123514 increasing the transfer of ATP-binding cassette (ABC) transporter expressing cells with retroviral vectors, by contacting with verapamil, diltiazem, quinidine, ritonavir and lentiviruses |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050123510 attenuated DNA viruses which increases production of chemokines |
| 06/09/2005 | CA2590257A1 Novel adenoviruses, nucleic acids that code for the same and the use of said viruses |
| 06/09/2005 | CA2548202A1 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 06/09/2005 | CA2546619A1 Il-23 and its receptor; related reagents and methods |
| 06/09/2005 | CA2546616A1 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 06/09/2005 | CA2546378A1 Mrna transfected antigen presenting cells |
| 06/09/2005 | CA2546287A1 Reduction of dermal scarring |
| 06/09/2005 | CA2546178A1 New use of adenovirus and nucleic acids coding therefor |
| 06/09/2005 | CA2545815A1 Adenoviral vectored tnf-a and chemoradiation to treat cancer |
| 06/08/2005 | EP1538202A2 Production of human alpha-galactosidase A |
| 06/08/2005 | EP1538162A2 Compositions for altering mucus secretion |
| 06/08/2005 | EP1537875A1 Preventive/remedy for arteriosclerosis |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537243A1 Method of diagnosing ovarian endometriosis |
| 06/08/2005 | EP1537237A2 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 06/08/2005 | EP1537227A2 Method for efficient rna interference in mammalian cells |
| 06/08/2005 | EP1537219A2 Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb |
| 06/08/2005 | EP1537208A1 Non-sequence complementary antiviral oligonucleotides |
| 06/08/2005 | EP1537207A2 Recombinant colstridium neurotoxin fragments |
| 06/08/2005 | EP1537206A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/08/2005 | EP1537145A1 Pharmaceutical compositions and medical treatments comprising notch ligand proteins |
| 06/08/2005 | EP1536850A1 Medical device having hydration inhibitor |
| 06/08/2005 | EP1536840A2 Formulation for inwardly transferring nucleic acids into eucaryotic cells |
| 06/08/2005 | EP1536837A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/08/2005 | EP1536816A2 Amelioration of effects of cigarette smoke |
| 06/08/2005 | EP1536812A2 Methods for modulating activity of the fxr nuclear receptor |
| 06/08/2005 | EP1536807A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
| 06/08/2005 | EP1536773A2 Method of manufacturing albumin microspheres comprising antisense oligonucleotides (oligomers) to nf-kb |
| 06/08/2005 | EP1536689A2 Gene therapy for critical limb ischemia with wild type or mutant enos |
| 06/08/2005 | EP1169441B1 Pharmaceutical compositions for the treatment of heart failure |
| 06/08/2005 | CN1624144A Process for high efficient fast concentriting adeno associated virus vector |
| 06/08/2005 | CN1624143A Recombined pseudorabies virus of expressing pig influenza virus hemagglutinin gene and application |
| 06/08/2005 | CN1624134A Expressing mini ribonucleic acid by bidirectional multi polyase III promoter |
| 06/08/2005 | CN1624126A Ret ligand (retl) for stimulating neural and renal growth |
| 06/08/2005 | CN1623604A Process for controlling birth female of mammal based on SRY gene |
| 06/08/2005 | CN1205336C Novel ribozyme of specificity cutting survivin, its medicinal composition and use |
| 06/07/2005 | US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods |
| 06/07/2005 | US6903188 Isolated functional derivative of an Mts protein that is preferably a multimeric protein complex. |
| 06/07/2005 | US6903185 Generating chimeric zinc finger protein; obtain nucleotide sequences coding chimeric protein, transform cells, express nucleotide sequences, recover protein |
| 06/07/2005 | US6903078 Applying wound healing agents comprising nucleotide sequences codes for platelet derived growth factors(PDGF), keratinocyte growth factors(KGF), insulin like growth factors(IGF) and insulin like growth factor binding proteins(IGFBP) |
| 06/07/2005 | US6903072 Polypeptide for use in the treatment of wounds, liver, inflammatory, kidney, lung and viral disorders |
| 06/07/2005 | US6902933 Transfection of preferential cells; obtain immbolized nucleotide sequences, incubate with cells, recover transfected cells |
| 06/07/2005 | US6902929 Comprises capsid particles of murine leukemia virus and envelope proteins of human/simian immunodeficiency virus |
| 06/07/2005 | US6902907 Cystic fibrosis gene |
| 06/07/2005 | US6902885 For detecting viral and cellular polypeptide interactions |
| 06/07/2005 | US6902731 Transcription factors; for arterial administration via stent |
| 06/02/2005 | WO2005049850A2 Compositions and methods for systemic nucleic acid sequence delivery |
| 06/02/2005 | WO2005049845A2 Oncolytic herpes simplex virus encoding a heterologous nitroreductase |
| 06/02/2005 | WO2005049844A2 Vectors, mutant viruses and methods for generating mutant viruses |
| 06/02/2005 | WO2005049838A2 Syk-targeted nucleic acid interference |
| 06/02/2005 | WO2005049832A2 FcϜRIIA-SPECIFIC NUCLEIC ACID INTERFERENCE |
| 06/02/2005 | WO2005049822A1 Method of growing myocardial cells |
| 06/02/2005 | WO2005049820A1 Substance binding to transcriptional factor |
| 06/02/2005 | WO2005049800A2 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell |
| 06/02/2005 | WO2005049793A2 Methods and compositions for combinatorial approaches to cancer gene therapy |
| 06/02/2005 | WO2005049647A2 Compositions comprising melittin-derved peptides and methods for the potentiation of immune responses against target antigens |
| 06/02/2005 | WO2005049630A2 Antisense modulation of kinesin-like 1 expression |
| 06/02/2005 | WO2005049094A1 A mixed complementary viral vector for gene therapy |
| 06/02/2005 | WO2005049093A1 Use of microparticles for antigen delivery |
| 06/02/2005 | WO2005049092A1 Ocular tissue modification |
| 06/02/2005 | WO2005049084A2 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure |
| 06/02/2005 | WO2005048997A1 Nanoparticles for delivery of a pharmacologically active agent |
| 06/02/2005 | WO2005048993A2 Minimization of drug oxidation in drug irradiated excipients formulations |
| 06/02/2005 | WO2005048957A2 Novel insertion sites in pox vectors |
| 06/02/2005 | WO2005048943A2 Compositions and methods for synergistic induction of antitumor immunity |
| 06/02/2005 | WO2005048930A2 Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| 06/02/2005 | WO2005048914A2 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 06/02/2005 | WO2005030253A9 Photocleavable dna transfer agent |
| 06/02/2005 | WO2005018575A3 Estrogen receptor modulators and uses thereof |
| 06/02/2005 | WO2005014836A3 Chimaeric vector system |
| 06/02/2005 | WO2005014785A3 Conditionally-immortalized hematopoietic progenitor cell lines |
| 06/02/2005 | WO2005012483A3 Vpr selective rnai agents and methods for using the same |
| 06/02/2005 | WO2005005637A3 Herpes simplex virus comprising a genetically modified glycoprotein d |
| 06/02/2005 | WO2005005613A3 Dsrna induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein |
| 06/02/2005 | WO2005001110A3 Transcriptional regulation of gene expression by small double-stranded modulatory rna |
| 06/02/2005 | WO2004099363A3 Dermal micro organs, methods and apparatuses for producing and using the same |
| 06/02/2005 | WO2004076648A3 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 06/02/2005 | WO2004076633A3 Hypoxia inducible vegf plasmid for ischemic disease |
| 06/02/2005 | WO2004071414A3 Therapeutic anti-hcv (al9) compounds |
| 06/02/2005 | WO2004058940A9 Sirna-mediated gene silencing |
| 06/02/2005 | WO2004041212A3 Apkc isoforms in nervous system disorders and cancer |
| 06/02/2005 | WO2004037182A3 Active specific immunotherapy of cancer metastasis |
| 06/02/2005 | WO2004032614A3 Animal with modification of cytoplasmic dynein heavy chain 1 gene |